Symrise AG

SY1

DE000SYM9999

Specialty Chemicals

Market Closed - Xetra Other stock markets 11:44:53 2024-04-19 am EDT			5-day change	1st Jan Change
105.4 ^EUR	+1.74%		+0.72%	+5.78%

Apr. 08	SYMRISE AG : Gets a Neutral rating from Barclays	ZD
Apr. 05	SYMRISE AG : Gets a Neutral rating from Deutsche Bank	ZD

SYMRISE AG : Goldman Sachs remains its Buy rating

October 05, 2020 at 09:14 am EDT

Analyst Theodora Lee Joseph from Goldman Sachs research considers the stock attractive and recommends it with a Buy rating. The target price has been lifted and is now set at EUR 127 compared to EUR 123 before.

Latest news about Symrise AG

SYMRISE AG : Gets a Neutral rating from Barclays	Apr. 08	ZD
SYMRISE AG : Gets a Neutral rating from Deutsche Bank	Apr. 05	ZD
SYMRISE AG : UBS reiterates its Buy rating	Apr. 03	ZD
Goldman raises target for Symrise to 101 euros - 'Sell'	Mar. 28	DP
SYMRISE AG : Gets a Sell rating from Goldman Sachs	Mar. 28	ZD
SYMRISE AG : DZ Bank reiterates its Neutral rating	Mar. 27	ZD
SYMRISE AG : Goldman Sachs keeps a Sell rating	Mar. 26	ZD
JPMorgan raises target for Symrise to 120 euros - 'Overweight'	Mar. 25	DP
SYMRISE AG : JP Morgan keeps its Buy rating	Mar. 22	ZD
SYMRISE AG : Warburg Research sticks Neutral	Mar. 22	ZD
SYMRISE AG : Gets a Neutral rating from Deutsche Bank	Mar. 11	ZD
Stagnant Eurozone Economy Drag German Stocks Lower	Mar. 08	MT
Berenberg raises target for Symrise to 126 euros - 'Buy'	Mar. 08	DP
Baader Bank raises target for Symrise to 115 euros - 'Add'	Mar. 08	DP
SYMRISE AG : Receives a Buy rating from Baader Bank	Mar. 08	ZD
SYMRISE AG : Receives a Buy rating from Berenberg	Mar. 08	ZD
SYMRISE AG : JP Morgan gives a Buy rating	Mar. 08	ZD
SYMRISE : UBS raises its price target	Mar. 07	CF
SYMRISE AG : Deutsche Bank remains Neutral	Mar. 07	ZD
SYMRISE AG : Barclays remains Neutral	Mar. 07	ZD
UBS raises target for Symrise to 120 euros - 'Buy'	Mar. 07	DP
SYMRISE AG : JP Morgan gives a Buy rating	Mar. 07	ZD
SYMRISE AG : UBS reaffirms its Buy rating	Mar. 07	ZD
SYMRISE AG : Jefferies reiterates its Buy rating	Mar. 06	ZD
Jefferies rates Symrise at 'Buy' - Target 120 euros	Mar. 06	DP

Chart Symrise AG

Duration

Period

More charts

Company Profile

Symrise AG is one of the world's leaders in developing, producing and marketing scents, flavors and functional ingredients. Net sales break down by family of products as follows: - nutritional ingredients (63%): for use in the manufacture of food products (beverages, candies, chocolates, cereals, dairy products, snacks, sauces, instant noodles, etc.) and in the manufacture of animal and fish feed; - perfumes and flavours (37%): perfumes, menthols, aromatic ingredients and chemicals for personal care products, oral care products, cleaning products, cosmetics, etc. Net sales are distributed geographically as follows: Germany (8.1%), Europe/Middle East/Africa (31.6%), the United States (24.4%), North America (2.1%), Asia/Pacific (20.7%) and Latin America (13.1%).

Sector

Specialty Chemicals

Calendar

2024-04-25 - Q1 2024 Sales and Revenue Release - Trading Update

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Ratings for Symrise AG

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

105.4 EUR

Average target price

113.5 EUR

Spread / Average Target

+7.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
SYMRISE AG	+5.78%	15.44B
ECOLAB INC.	+9.99%	62.67B
SIKA AG	-6.50%	45.97B
GIVAUDAN SA	+13.40%	39.51B
FUJIFILM HOLDINGS CORPORATION	+17.90%	26.04B
EMS-CHEMIE HOLDING AG	+1.03%	17.71B
CELANESE CORPORATION	-0.59%	17.25B
POSCO FUTURE M CO., LTD.	-29.39%	14.54B
ALBEMARLE CORPORATION	-22.38%	13.14B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-25.29%	13.09B

Other Specialty Chemicals

Symrise AG

Equities

SY1

DE000SYM9999

Specialty Chemicals

SYMRISE AG : Goldman Sachs remains its Buy rating

EPS Revisions